These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9485099)

  • 1. Mature type of skin collagen crosslink, histidinohydroxylysinonorleucine, is significantly increased in the skin of systemic sclerosis patients.
    Ishikawa O; Kondo A; Miyachi Y
    Arthritis Rheum; 1998 Feb; 41(2):376-7. PubMed ID: 9485099
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of singlet oxygen on the extracellular matrix protein collagen: oxidation of the collagen crosslink histidinohydroxylysinonorleucine and histidine.
    Au V; Madison SA
    Arch Biochem Biophys; 2000 Dec; 384(1):133-42. PubMed ID: 11147824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increase of mature type skin collagen cross-link, histidinohydroxylysinonorleucine, in the sclerotic skin of morphea.
    Tamura M; Ishikawa O
    J Dermatol Sci; 2001 Jan; 25(1):83-6. PubMed ID: 11154869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma).
    Buckingham RB; Prince RK; Rodnan GP; Taylor F
    J Lab Clin Med; 1978 Jul; 92(1):5-21. PubMed ID: 351108
    [No Abstract]   [Full Text] [Related]  

  • 5. [Collagen metabolism in systemic scleroderma].
    Lebedev DA
    Vopr Med Khim; 1978; 24(6):789-95. PubMed ID: 734979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis.
    Ono S; Yamauchi M
    Ann Neurol; 1992 Mar; 31(3):305-10. PubMed ID: 1637138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of extracorporeal photochemotherapy on alpha1(I) and alpha1(III) procollagen mRNA expression in systemic sclerosis skin tissue.
    Ohtsuka T; Okita H; Yamakage A; Yamazaki S
    Arch Dermatol Res; 2002 Feb; 293(12):642-5. PubMed ID: 11875648
    [No Abstract]   [Full Text] [Related]  

  • 8. [Apatite and collagen as constituents of the calcium deposits in progressive scleroderma].
    Brenke A; Haupt R; Loreck D
    Dermatol Monatsschr; 1986; 172(4):235-7. PubMed ID: 3721031
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine.
    Uitto J; Helin P; Rasmussen O; Lorenzen I
    Ann Clin Res; 1970 Sep; 2(3):228-34. PubMed ID: 5473163
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of collagen protein biosynthesis in fibroblast cultures from the skin of patients with systemic scleroderma].
    Vladimirtsev VA; Guseva NG; Khokhlova IuV; Oskilko TG
    Vopr Revm; 1981; (2):44-50. PubMed ID: 6275609
    [No Abstract]   [Full Text] [Related]  

  • 11. Scleroderma-like remodeling induced by type V collagen.
    Bezerra MC; Teodoro WR; de Oliveira CC; Velosa AP; Ogido LT; Gauditano G; Parra ER; Capelozzi VL; Yoshinari NH
    Arch Dermatol Res; 2006 Jul; 298(2):51-7. PubMed ID: 16710740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism of collagen in progressive scleroderma and dermatomyositis].
    Kreysel HW; Blonck-Kranold D; Osborn H; Kimmig J
    Hautarzt; 1976 May; 27(5):226-33. PubMed ID: 783083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
    Kissin EY; Merkel PA; Lafyatis R
    Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study on application of lathyrogen therapy to progressive systemic sclerosis.
    Okuda M; Yamane K; Nishido T
    Bull Tokyo Med Dent Univ; 1974 Mar; 21(1):45-65. PubMed ID: 4525661
    [No Abstract]   [Full Text] [Related]  

  • 15. Collagen V nasal tolerance in experimental model of systemic sclerosis.
    Velosa AP; Teodoro WR; de Oliveira CC; Dos Santos Filho A; Moutinho RF; Santos AG; Vendramini MB; Bueno C; Parra ER; Capelozzi VL; Yoshinari NH
    Arch Dermatol Res; 2007 Jul; 299(4):177-89. PubMed ID: 17297604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis].
    Liu T; Zhang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):748-52. PubMed ID: 19024305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen fibril diameter and its relation to cross-linking of collagen in the skin of patients with amyotrophic lateral sclerosis.
    Ono S; Yamauchi M
    J Neurol Sci; 1993 Oct; 119(1):74-8. PubMed ID: 8246013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased skin collagen extractability and proportions of collagen type III are not normalized after 6 months healing of human excisional wounds.
    Robins SP; Milne G; Duncan A; Davies C; Butt R; Greiling D; James IT
    J Invest Dermatol; 2003 Aug; 121(2):267-72. PubMed ID: 12880417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.